Cargando…
Antithrombotic therapy in the prevention of ischemic stroke /
Stroke is the most common cause of adult mortality in the United States. Antithrombotic agents form the mainstay of stroke prevention. Aspirin produces a modest reduction in the risk of second stroke and transient ischemic attack (TIA, mini-stroke) and is widely recommended for initial therapy. The...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Oxford ; New York :
Oxford University Press,
2010.
|
| Colección: | Oxford American pocket notes.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | EBSCO_ocn864899958 | ||
| 003 | OCoLC | ||
| 005 | 20231017213018.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 131210s2010 enka ob 000 0 eng d | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d YDXCP |d OCLCO |d NLGGC |d OCLCQ |d D6H |d AGLDB |d OCLCO |d OCLCA |d STF |d OCLCO |d OCLCF |d VNS |d OCLCO |d OCLCQ |d VTS |d OCLCO |d TOF |d OCLCO |d AU@ |d OCLCO |d OCLCQ |d OCLCO |d OCLCA |d REC |d M8D |d OCLCO |d OCLCA |d VLY |d OCLCQ |d OCLCO |d OCLCQ | ||
| 019 | |a 864851322 |a 1162566422 |a 1241962604 |a 1300451681 | ||
| 020 | |a 9780199774449 |q (electronic bk.) | ||
| 020 | |a 0199774447 |q (electronic bk.) | ||
| 020 | |z 9780195394320 | ||
| 020 | |z 0195394321 | ||
| 029 | 1 | |a AU@ |b 000054196644 | |
| 029 | 1 | |a DEBBG |b BV043037287 | |
| 029 | 1 | |a DEBSZ |b 421235853 | |
| 029 | 1 | |a GBVCP |b 800037634 | |
| 035 | |a (OCoLC)864899958 |z (OCoLC)864851322 |z (OCoLC)1162566422 |z (OCoLC)1241962604 |z (OCoLC)1300451681 | ||
| 050 | 4 | |a RC388.5 |b .B43 2010eb | |
| 060 | 4 | |a WL 355 |b B396 2010 | |
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.81061 |2 22 |
| 049 | |a UAMI | ||
| 100 | 1 | |a Becker, Richard C. | |
| 245 | 1 | 0 | |a Antithrombotic therapy in the prevention of ischemic stroke / |c by Richard C. Becker, Frederick A. Spencer. |
| 264 | 1 | |a Oxford ; |a New York : |b Oxford University Press, |c 2010. | |
| 300 | |a 1 online resource (45 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Oxford American pocket notes | |
| 504 | |a Includes bibliographical references. | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a Cover; Contents; Introduction and Epidemiology; Pathophysiology; Regulatory Factors in Thrombus Formation; Cellular Interactions in Atherothrombosis; Classification of Stroke; Managing Risk Factors for Recurrent Stroke; Antithrombotic Therapy for Prevention of Recurrent TIA and Stroke; Aspirin; Mechanism of Action; Pharmacokinetics; Adverse Effects; Aspirin Administration in Clinical Practice; Secondary Prevention of Vascular Events and Stroke; Aspirin Dosing in Prevention of Recurrent TIA/Stroke; Thienopyridines (Clopidogrel, Ticlopidine, and Prasugrel); Mechanism of Action; Clopidogrel | |
| 505 | 8 | |a PharmacokineticsAbsorption; Adverse Effects; Prevention of Vascular Events; Ticlopidine; Prasugrel; Dipyridamole, Extended-Release Dipyridamole/Aspirin Combination (Aggrenox); Mechanism of Action; Pharmacokinetics; Pharmacodynamics; Adverse Effects; Administration in Older Patients; Clinical Experience; Cilostazol; References | |
| 520 | |a Stroke is the most common cause of adult mortality in the United States. Antithrombotic agents form the mainstay of stroke prevention. Aspirin produces a modest reduction in the risk of second stroke and transient ischemic attack (TIA, mini-stroke) and is widely recommended for initial therapy. The thienopyridines (Ticlid) and clopodogrel (Plavix) are alternatives for secondary prevention in patients who do not respond to or cannot take aspirin. They are no more effective than aspirin and have been associated with thrombotic thrombocytopenic purpura. The combination of aspirin and extended-rel. | ||
| 546 | |a English. | ||
| 590 | |a eBooks on EBSCOhost |b EBSCO eBook Subscription Academic Collection - Worldwide | ||
| 650 | 0 | |a Transient ischemic attack |x Chemotherapy. | |
| 650 | 0 | |a Transient ischemic attack |x Prevention. | |
| 650 | 0 | |a Fibrinolytic agents. | |
| 650 | 2 | |a Ischemic Attack, Transient |x drug therapy | |
| 650 | 2 | |a Ischemic Attack, Transient |x prevention & control | |
| 650 | 2 | |a Fibrinolytic Agents | |
| 650 | 6 | |a Accident ischémique transitoire |x Chimiothérapie. | |
| 650 | 6 | |a Fibrinolytiques. | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
| 650 | 7 | |a Fibrinolytic agents. |2 fast |0 (OCoLC)fst00923665 | |
| 700 | 1 | |a Spencer, Fredrick A., |c MD. | |
| 776 | 0 | 8 | |i Print version: |a Becker, Richard C. |t Antithrombotic therapy in the prevention of ischemic stroke |z 9780195394320 |w (DLC) 2012359345 |w (OCoLC)620302656 |
| 830 | 0 | |a Oxford American pocket notes. | |
| 856 | 4 | 0 | |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=669957 |z Texto completo |
| 938 | |a EBSCOhost |b EBSC |n 669957 | ||
| 938 | |a YBP Library Services |b YANK |n 11406315 | ||
| 994 | |a 92 |b IZTAP | ||